CIK: 0001631134 · Show all filings
Period: Q2 2025 (← Previous) (Next →)
Filing Date: Aug 14, 2025
Total Value ($000): $1,635,019 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| NTRA | Natera Inc | 1,550,280 | $261,904 | 16.0% | $9.81 | +1488.7% | COM | 632307104 |
| GILD | Gilead Sciences Inc | 1,050,308 | $116,448 | 7.1% | $97.45 | +7.1% | COM | 375558103 |
| LLY | Eli Lilly and Co | 97,018 | $75,628 | 4.6% | $801.58 | -3.5% | COM | 532457108 |
| JAZZ | Jazz Pharmaceuticals PLC | 694,096 | $73,657 | 4.5% | $113.27 | -4.1% | SHS USD | G50871105 |
| VERA | Vera Therapeutics Inc | 2,793,987 | $65,826 | 4.0% | $15.35 | +46.5% | CL A | 92337R101 |
| IWM | iShares TR | 250,000 | $53,948 | 3.3% | — | — | Put | 464287655 |
| ABBV | AbbVie Inc | 265,850 | $49,347 | 3.0% | $182.67 | 0.0% | COM | 00287Y109 |
| IBB | iShares TR | 375,000 | $47,441 | 2.9% | — | — | Put | 464287556 |
| BSX | Boston Scientific Corp | 431,200 | $46,315 | 2.8% | $101.18 | 0.0% | COM | 101137107 |
| DXCM | Dexcom Inc | 523,694 | $45,713 | 2.8% | $76.62 | +2.3% | COM | 252131107 |
| IDYA | IDEAYA Biosciences Inc | 2,147,795 | $45,147 | 2.8% | $25.35 | -24.3% | COM | 45166A102 |
| BBIO | BridgeBio Pharma Inc | 993,093 | $42,882 | 2.6% | $34.41 | +5.7% | COM | 10806X102 |
| ISRG | Intuitive Surgical Inc | 70,642 | $38,388 | 2.3% | $522.53 | +0.1% | COM | 46120E602 |
| RYTM | Rhythm Pharmaceuticals Inc | 586,010 | $37,030 | 2.3% | $53.22 | +15.0% | COM | 76243J105 |
| AVBP | Arrivent BioPharma Inc | 1,696,752 | $36,938 | 2.3% | $20.17 | +2.9% | COM | 04272N102 |
| ROIV | Roivant Sciences Ltd | 3,088,814 | $34,811 | 2.1% | $10.83 | +0.1% | SHS | G76279101 |
| SLNO | Soleno Therapeutics Inc | 415,219 | $34,787 | 2.1% | $45.28 | +65.3% | COM | 834203309 |
| UTHR | United Therapeutics Corp | 118,513 | $34,055 | 2.1% | $298.86 | 0.0% | COM | 91307C102 |
| INSM | Insmed Inc | 313,923 | $31,593 | 1.9% | $51.55 | +48.3% | COM PAR $.01 | 457669307 |
| — | Akero Therapeutics Inc | 548,788 | $29,283 | 1.8% | $41.39 | — | COM | 00973Y108 |
| SUPN | Supernus Pharmaceuticals Inc | 799,253 | $25,192 | 1.5% | $34.25 | -6.4% | COM | 868459108 |
| ANAB | AnaptysBio Inc | 1,032,362 | $22,918 | 1.4% | $17.55 | +19.3% | COM | 032724106 |
| RAPP | Rapport Therapeutics Inc | 1,995,594 | $22,690 | 1.4% | $23.12 | -54.1% | COM | 75383L102 |
| QURE | Uniqure NV | 1,558,356 | $21,723 | 1.3% | $13.65 | -1.5% | SHS | N90064101 |
| — | Merus N V | 404,562 | $21,280 | 1.3% | $52.60 | — | COM | N5749R100 |
| AZN | AstraZeneca PLC | 293,661 | $20,521 | 1.3% | $69.88 | — | SPONSORED ADR | 046353108 |
| PTCT | PTC Therapeutics Inc | 375,939 | $18,361 | 1.1% | $49.90 | -4.9% | COM | 69366J200 |
| — | Inozyme Pharma Inc | 4,280,308 | $17,121 | 1.0% | $14.88 | — | COM | 45790W108 |
| COGT | Cogent Biosciences Inc | 2,355,505 | $16,913 | 1.0% | $7.16 | -22.5% | COM | 19240Q201 |
| REPL | Replimune Group Inc | 1,806,529 | $16,783 | 1.0% | $12.12 | -28.0% | COM | 76029N106 |
| RNAM | Avidity Biosciences Inc | 584,801 | $16,608 | 1.0% | $30.72 | -3.0% | COM | 05370A108 |
| SMMT | Summit Therapeutics Inc | 700,000 | $14,896 | 0.9% | — | — | Call | 86627T108 |
| SNDX | Syndax Pharmaceuticals Inc | 1,524,440 | $14,276 | 0.9% | $16.13 | -31.8% | COM | 87164F105 |
| RYTM | Rhythm Pharmaceuticals Inc | 225,000 | $14,218 | 0.9% | $53.22 | +15.0% | Put | 76243J105 |
| REPL | Replimune Group Inc | 1,500,000 | $13,935 | 0.9% | $12.12 | -28.0% | Put | 76029N106 |
| — | Cidara Therapeutics Inc | 251,031 | $12,228 | 0.7% | $48.71 | — | COM | 171757206 |
| IMTX | Immatics N.V | 2,240,528 | $12,054 | 0.7% | $5.85 | -15.2% | SHS | N44445109 |
| ROIV | Roivant Sciences Ltd | 1,000,000 | $11,270 | 0.7% | $10.83 | +0.1% | Call | G76279101 |
| EXAS | Exact Sciences Corp | 208,300 | $11,069 | 0.7% | $50.80 | 0.0% | COM | 30063P105 |
| PHVS | Pharvaris N V | 585,532 | $10,305 | 0.6% | $20.79 | -22.5% | COM | N69605108 |
| INBX | Inhibrx Biosciences Inc | 708,678 | $10,113 | 0.6% | $14.93 | -13.4% | COM | 45720N103 |
| RCUS | Arcus Biosciences Inc | 1,216,016 | $9,898 | 0.6% | $11.15 | -23.4% | COM | 03969F109 |
| — | Y-mAbs Therapeutics Inc | 2,194,278 | $9,896 | 0.6% | $26.75 | — | COM | 984241109 |
| AXSM | Axsome Therapeutics Inc | 93,610 | $9,772 | 0.6% | $80.00 | +32.4% | COM | 05464T104 |
| BIOA | BioAge Labs Inc | 2,304,901 | $9,519 | 0.6% | $20.04 | -79.9% | COM | 09077V100 |
| EWTX | Edgewise Therapeutics Inc | 716,873 | $9,398 | 0.6% | $16.17 | -10.8% | COM | 28036F105 |
| IMNM | Immunome Inc | 778,476 | $7,240 | 0.4% | $18.47 | -55.6% | COM | 45257U108 |
| DYN | Dyne Therapeutics Inc | 614,865 | $5,854 | 0.4% | $20.14 | -45.3% | COM | 26818M108 |
| SVRA | Savara Inc | 2,457,352 | $5,603 | 0.3% | $4.16 | -34.7% | COM | 805111101 |
| — | Cidara Therapeutics Inc | 100,000 | $4,871 | 0.3% | $48.71 | — | Call | 171757206 |
| COGT | Cogent Biosciences Inc | 660,000 | $4,739 | 0.3% | $7.16 | -22.5% | Call | 19240Q201 |
| APGE | Apogee Therapeutics Inc | 76,180 | $3,308 | 0.2% | $38.04 | 0.0% | COM | 03770N101 |
| — | Nextcure Inc | 2,671,856 | $1,229 | 0.1% | $10.01 | — | COM | 65343E108 |
| ESTA | Establishment Labs Hldgs Inc | 28,120 | $1,201 | 0.1% | $47.17 | -26.1% | COM | G31249108 |
| JBIO | Jade Biosciences Inc | 107,391 | $1,073 | 0.1% | $33.31 | 0.0% | COM | 008064206 |
| — | Metsera Inc | 36,191 | $1,030 | 0.1% | $27.22 | — | COM | 59267L107 |
| SRRK | Scholar Rock Hldg Corp | 26,440 | $937 | 0.1% | $38.47 | -18.4% | COM | 80706P103 |
| BOLT | Bolt Biotherapeutics Inc | 137,721 | $795 | 0.0% | $6.62 | 0.0% | COM | 097702203 |
| WVE | Wave Life Sciences Ltd | 117,903 | $766 | 0.0% | $6.60 | 0.0% | SHS | Y95308105 |
| GPCR | Structure Therapeutics Inc | 34,353 | $712 | 0.0% | $34.06 | — | SPONSORED ADS | 86366E106 |
| PRAX | Praxis Precision Medicines Inc | 15,717 | $661 | 0.0% | $62.45 | -39.0% | COM | 74006W207 |
| — | Ikena Oncology Inc | 382,616 | $513 | 0.0% | $2.66 | — | COM | 45175G108 |
| IRON | Disc Medicine Inc | 7,312 | $387 | 0.0% | $42.38 | +10.8% | COM | 254604101 |